The global angiography devices market was valued at $8,780.5 million in 2021, and is projected to reach $15,931.1million by 2031, registering a CAGR of 6.0% from 2022 to 2031.
Introduction
The global angiography devices market is witnessing steady growth, fueled by the rising prevalence of cardiovascular diseases and advancements in imaging technology. Angiography plays a vital role in diagnosing and treating conditions such as coronary artery disease, aneurysms, and peripheral vascular disorders. As demand for minimally invasive diagnostics surges, angiography devices are becoming central to modern cardiovascular care.
The global angiography devices market was valued at $8,780.5 million in 2021, and is projected to reach $15,931.1million by 2031, registering a CAGR of 6.0% from 2022 to 2031.
Angiography devices are imaging tools used to visualize the blood vessels after the injection of a contrast dye. They include equipment such as:
These tools help detect blockages, stenosis, or abnormalities in the vascular system with high accuracy and speed.
The angiography devices market is poised for continued expansion, supported by AI integration, portable imaging systems, and increasing investment in cardiovascular health. Companies are focusing on personalized and hybrid imaging technologies that enhance clinical decision-making.
Conclusion Angiography devices are indispensable in the diagnosis and treatment of vascular and cardiac diseases. As the demand for efficient, non-invasive imaging grows, the angiography devices market will continue to evolve, offering cutting-edge solutions that improve patient outcomes and reshape cardiovascular care globally.